Publications by authors named "Ya-Li Lyu"
Int J Ophthalmol
September 2022
Article Synopsis
- The study aimed to assess the effectiveness and safety of HLX04-O, a new formulation of a biosimilar drug, for treating wet age-related macular degeneration (wAMD) in a phase 1/2 clinical trial.
- The trial involved administering HLX04-O injections to eligible patients every four weeks, with evaluations of both treatment efficacy and any adverse effects conducted monthly.
- One participant showed significant improvement in eye health and vision after six treatment cycles, and no adverse effects were reported, suggesting that HLX04-O is well tolerated; however, further research is needed to validate these findings.
